DVA · 10-Q · 2026Q2 · Full report

Liquidity and Cash Position

DAVITA INC. · 2026-08-04 · Importance 43 · Surprise 6 · Contradicted

DaVita had $1.435 billion of available capacity and $65 million drawn under its $1.5 billion revolving credit facility as of June 30, 2026. No letters of credit were outstanding under the revolving facility, while approximately $188 million of letters of credit were outstanding under a separate bilateral secured facility. Management stated that operating cash flow, available credit, and capital-market access should fund scheduled debt service and other obligations for at least the next 12 months.

Key facts

• As of June 30, 2026, we had $1.435 billion available and $65 million drawn on our $1.5 billion revolving line of credit under our senior secured credit facilities. source
• Total noncontrolling interests subject to put provisions as of June 30, 2026: $1,561,416 source
• Approximately $188 million in letters of credit outstanding under a separate bilateral secured letter of credit facility as of June 30, 2026. source
• We have certain potential commitments associated with letters of credit, working capital funding or other financing to certain nonconsolidated businesses that we manage and in which we own a noncontrolling equity interest or which are wholly-owned by third parties. source
• As of June 30, 2026, we have outstanding purchase agreements with various suppliers to purchase set amounts of dialysis equipment, parts, pharmaceuticals, supplies and technology services and, if we fail to meet the minimum purchase commitments, we are required to pay the difference to the supplier. source
• Available on revolving line of credit as of June 30, 2026: $1,435,000 available and $65,000 drawn on $1,500,000 facility source
• Net cash used in investing activities for the six months ended June 30, 2026: $(333) million source
• Net cash used in financing activities for the six months ended June 30, 2026: $(484) million source

Impact estimates